Sam Lee is President at Cocrystal Pharma, Inc. (COCP). They have made 1 open-market trade across 1 company since 2016, most recently 2024-10-09.
CIK 0001602074
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| COCP | 76,355 | $80K |
Shares reported on the most recent Form 4, priced at the 2024-10-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| COCP | SELL | 2016-12-23 | 2016-12-23 | $0.44 | $968K | +15.4% | +8.9% | +8.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.